Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satheesh Chonat

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Blood Advances|December 28, 2023
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapyMichelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, et al.
Pediatric Blood & Cancer|September 24, 2022
Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology centerSara Graciaa, Segun Adeagbo, Grace Fong, et al.
Blood Advances|March 29, 2024
Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuriaSatheesh Chonat, Alexander Kulagin, Alexey Maschan, et al.
British Journal of Haematology|March 9, 2025
Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programmeJorune Balciuniene, Saliha Yilmaz, Satheesh Chonat, et al.
Blood Advances|January 25, 2018
Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in miceSeema R Patel, Ashley Bennett, Kathryn Girard-Pierce, et al.
Transfusion|March 9, 2019
Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patientsChristina L Dean, Cheryl L Maier, Satheesh Chonat, et al.
Cancer Reports (Hoboken, N.J.)|July 6, 2022
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood componentsJason Stevenson, Nicholas P DeGroote, Frank Keller, et al.
Journal of Clinical Immunology|June 26, 2021
T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLHOded Shamriz, Deepak Kumar, Jenny Shim, et al.
Frontiers in Pediatrics|January 15, 2021
Complement Inhibition in Severe COVID-19 Acute Respiratory Distress SyndromeSharmila Raghunandan, Cassandra D Josephson, Hans Verkerke, et al.
Transplantation and Cellular Therapy|December 25, 2023
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in ChildrenMichelle L Schoettler, Seema Patel, Elyse Bryson, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Blood Advances|December 28, 2023
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapyMichelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, et al.
Pediatric Blood & Cancer|September 24, 2022
Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology centerSara Graciaa, Segun Adeagbo, Grace Fong, et al.
Blood Advances|March 29, 2024
Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuriaSatheesh Chonat, Alexander Kulagin, Alexey Maschan, et al.
British Journal of Haematology|March 9, 2025
Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programmeJorune Balciuniene, Saliha Yilmaz, Satheesh Chonat, et al.
Blood Advances|January 25, 2018
Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in miceSeema R Patel, Ashley Bennett, Kathryn Girard-Pierce, et al.
Transfusion|March 9, 2019
Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patientsChristina L Dean, Cheryl L Maier, Satheesh Chonat, et al.
Cancer Reports (Hoboken, N.J.)|July 6, 2022
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood componentsJason Stevenson, Nicholas P DeGroote, Frank Keller, et al.
Journal of Clinical Immunology|June 26, 2021
T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLHOded Shamriz, Deepak Kumar, Jenny Shim, et al.
Frontiers in Pediatrics|January 15, 2021
Complement Inhibition in Severe COVID-19 Acute Respiratory Distress SyndromeSharmila Raghunandan, Cassandra D Josephson, Hans Verkerke, et al.
Transplantation and Cellular Therapy|December 25, 2023
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in ChildrenMichelle L Schoettler, Seema Patel, Elyse Bryson, et al.
Pageof 9